(4-((2-Chloro-4-methylphenyl)carbamoyl)phenyl)boronic acid

Catalog No. :
ACVDZQ501
CAS No. :
913835-39-9
Molecular Formula :
C14H13BClNO3
Molecular Weight :
289.53

IUPAC Name:(4-((2-chloro-4-methylphenyl)carbamoyl)phenyl)boronic acid

(4-((2-Chloro-4-methylphenyl)carbamoyl)phenyl)boronic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4-((2-Chloro-4-methylphenyl)carbamoyl)phenyl)boronic acid
IUPAC Name(4-((2-chloro-4-methylphenyl)carbamoyl)phenyl)boronic acid
MDL No.N188084
Molecular FormulaC14H13BClNO3
Molecular Weight289.53
SMILESO=C(C1=CC=C(B(O)O)C=C1)NC2=CC=C(C)C=C2Cl
InChI KeyOLWULFVOADOJBR-UHFFFAOYSA-N
Synonym913835-39-9 | (4-((2-Chloro-4-methylphenyl)carbamoyl)phenyl)boronic acid | N-(2-Chloro-4-methylphenyl) 4-boronobenzamide | [4-[(2-chloro-4-methylphenyl)carbamoyl]phenyl]boronic acid | (4-((2-Chloro-4-methylphenyl)carbamoyl)-phenyl)boronic acid | {4-[(2-Chloro-4-met
CAS No.913835-39-9
PubChem CID44119165

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P264-P271-P302+P352-P305+P351+P338-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACVDZQ501 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNIRT390 route compound structure diagram
    ACNIRT39014047-29-1 In Stock
  4. Then
  5. ACVDZQ501 route product structure diagram
    ACVDZQ501913835-39-9
Inquiry

2. ACVDZQ501 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNWOF894 route compound structure diagram
    ACNWOF894332154-57-1 In Stock
  4. Then
  5. ACVDZQ501 route product structure diagram
    ACVDZQ501913835-39-9
Inquiry

Comments (0)